Re Max Holding

The Real Brokerage reported second-quarter revenue of $700.6 million, up 30% year over year, driven by a 27% increase in closed transactions to 62,380 sides. Non-GAAP adjusted EBITDA grew 38% to $27.6 million, while net loss was $8 million, including $11.6 million in acquisition-related costs tied to the pending RE/MAX transaction. Agent count rose 26% year over year to 35,348 at quarter end and has since exceeded 36,000. Gross margin declined to 8.3% from 8.9% a year earlier as capped agents accounted for 42% of closed sides, up 300 basis points. Management expects third-quarter revenue and adjusted EBITDA to decline sequentially due to normal seasonal patterns, and the company ended the quarter with $86.6 million in unrestricted cash and investments.

Class action attorney Juan Monteverde of Monteverde & Associates PC announced investigations into four proposed mergers. The firm is examining Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings where Neuphoria stockholders would own 11.1% of the combined company, Safety Insurance Group's sale to a Mapfre affiliate at $105.00 per share in cash, and RE/MAX Holdings' sale to The Real Brokerage where shareholders may receive 5.152 shares of the combined company or $13.80 in cash per share. The RE/MAX shareholder vote is scheduled for August 14, 2026. Monteverde & Associates PC, a national class action securities firm headquartered at the Empire State Building, has recovered millions of dollars for shareholders and was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

Several stocks made notable moves on Tuesday. CoStar fell 3.6% after its CFO departed, prompting a Baird downgrade. JPMorgan Chase rose 2.6% after reporting second-quarter results that beat Wall Street expectations. The Real Brokerage gained 4.5% after the Department of Justice granted early termination of the Hart-Scott-Rodino waiting period for its proposed merger with RE/MAX Holdings. Semtech rose 5.7% after Needham reiterated a Buy rating and $200 price target following investor meetings with executives. Paramount fell 2.9% after a coalition of 12 US states filed a lawsuit seeking to block its proposed $110 billion acquisition of Warner Bros. Discovery.

Halper Sadeh LLC, an investor rights law firm, is investigating NextEra Energy, Corebridge Financial, RE/MAX Holdings, and Apogee Therapeutics for potential violations of federal securities laws or breaches of fiduciary duties to shareholders in connection with their proposed transactions. The firm is examining NextEra Energy's merger with Dominion Energy, where NextEra shareholders would own approximately 74.5% of the combined company, and Corebridge Financial's merger with Equitable Holdings, in which each Corebridge share would be exchanged for one share of the combined company and Corebridge shareholders would own about 51% of the entity. Also under investigation is RE/MAX Holdings' sale to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in cash per share, and Apogee Therapeutics' sale to AbbVie for $135.11 per share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages them to contact the firm to discuss their rights at no cost.